ReviewJournal of cardiothoracic surgery2026
Pathological complete remission of pulmonary epithelioid hemangioendothelioma: a case report and literature review.
Review in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to report a case of pulmonary epithelioid hemangioendothelioma (PEH) achieving pathological complete remission following neoadjuvant treatment, thereby enhancing clinical understanding of this rare disease and providing valuable treatment insights. CASE PRESENTATION: The patient's imaging examination revealed a single large tumor on one side of the lung with lymph node metastasis. After treatment with albumin paclitaxel + carboplatin + bevacizumab, the tumor disappeared from the imaging findings, and postoperative pathology confirmed that the patient achieved pathological complete remission.
conclusionPEH is rare in clinical practice and is a type of malignant tumor without characteristic clinical manifestations, and the diagnosis relies on pathological and immunohistochemical examinations. Single or few lesions can be treated surgically, whereas those that cannot undergo surgery can be treated with chemotherapy and targeted therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.